Rapport Therapeutics RAPP
NASDAQ RAPP
$46.70 -0.95 (-1.99%)
As of: Sep 4, 2026 · 1:35 PM EDT

Rapport Therapeutics (RAPP) Market Capitalization (2024 - 2026)

Analysis

Rapport Therapeutics (RAPP) Market Capitalization (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Rapport Therapeutics 2.22 Bn 2.22 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.00 Bn
Mar 31, 2026 1.50 Bn
Dec 31, 2025 1.18 Bn
Sep 30, 2025 1.13 Bn
Jun 30, 2025 414.98 Mn
Mar 31, 2025 366.07 Mn
Dec 31, 2024 367.90 Mn
Sep 30, 2024 749.09 Mn
Jun 30, 2024 248.10 Mn